ArticleCancer medicine2022

Prolonged progression-free survival achieved by octreotide LAR plus transarterial embolization in low-to-intermediate grade neuroendocrine tumor liver metastases with high hepatic tumor burden.

Yiming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.